DCF Advisers, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,586,000
+3.5%
3,050,0000.0%0.86%
+6.7%
Q2 2023$1,532,625
+3.8%
3,050,000
-15.3%
0.81%
-10.4%
Q1 2023$1,476,000
+642.1%
3,600,0000.0%0.90%
+574.6%
Q4 2022$198,900
-77.5%
3,600,000
+132.3%
0.13%
-76.5%
Q3 2022$884,000
+116.7%
1,550,000
+106.7%
0.57%
+135.0%
Q2 2022$408,000
+91.5%
750,000
+87.5%
0.24%
+161.3%
Q1 2022$213,000
+0.9%
400,0000.0%0.09%
+8.1%
Q4 2021$211,000400,0000.09%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders